Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03970447
Title A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma (GBM AGILE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Global Coalition for Adaptive Research
Indications

glioblastoma

gliosarcoma

Therapies

Lomustine

Regorafenib

Temozolomide

Age Groups: senior | adult
Covered Countries USA | FRA | CAN

Additional content available in CKB BOOST